IDSA is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Pharmacy credit will be available for select sessions at IDWeek. Please refer to the CME/CPE Credit Tracker in the Final Program for a detailed listing and the Accreditation Council for Pharmacy Education (ACPE) number assigned to each applicable session. Pharmacists must attend each selected session in its entirety to receive CPE credit.
IDWeek brings together physicians, scientists, and other health care professionals involved in research, patient care, public health, disease prevention, and education in the field of infectious diseases. There are no prerequisites for attendance. This meeting provides broad continuing educational courses and comprehensive educational experiences in the major facets of infectious diseases: pathophysiology, diagnosis, treatment and prevention. The courses combine expert reviews of the traditional field of infectious diseases with emphasis on the most contemporary trends, including emerging infections, new diagnostics, vaccines, and therapeutics.
IDSA designates this educational activity for a maximum 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim credit commensurate with the extent of their participation in the activity. IDSA designates this educational activity for a maximum 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim credit commensurate with the extent of their participation in the activity.
Back to top
In accordance with the ACCME Standards for Commercial Support, IDSA must provide balance, objectivity, and scientific rigor in all sponsored educational activities accredited for CME. The intent of the disclosure(s) is to provide the audience with information on which they can make their own independent judgments pertaining to program content.
Therefore, IDSA requires all faculty to disclose significant, relevant financial relationships with which they or a spouse/partner have, or have had, within the past 12 months with companies or commercial supporters of any products/services that is related to the research being presented at the IDWeek (for example, employee, grants, research support, speaker, sponsors, stockholder, etc.). In addition to verbal and written disclosures, faculty are required to provide on the first slide of PowerPoint presentations, any significant financial interest(s)/relationship(s) or that there is 'Nothing to disclose.'
IDSA follows and supports the ACCME guidelines for commercial support.
It is the policy of IDSA that faculty resolve any conflicts of interest prior to IDWeek.
faculty are requested to agree, to the following methods of resolving conflicts
of interest(s) prior to the beginning of IDWeek:
If participating in the development of program content, to refrain from developing those components of the meeting that support or promote any financial relationship(s).
· To disclose to the audience prior to IDWeek, any additional financial relationship(s).
· If invited to review abstracts, to refrain from peer reviewing abstracts containing research to which the respective faculty have contributed.
· If trade names of products and/or services are used, to use trade names from several companies, not just trade names from a single company.
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America